Clinical Trial Update: Efficacy Study on Cognitive Functions in Schizophrenic Patients [Phase 4]

View source ↗

Summary

A Phase 4 efficacy study evaluating cognitive functions in schizophrenia patients has completed, sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Sanofi | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED